Chairmans Corner

Martin Bonde

Martin Bonde (Formand), 2016-2018

CEO – PhD, BComm
VacciBody

  • Obtained his PhD in 1990 from the Department of Biochemistry at the Technical University of Denmark. Earned a BComm in foreign trade economy from Copenhagen Business School in 1991
  • After his PhD, started his industry career in Dako AS, followed by Ostemeter AS (CEO), Torsana Biosensor AS (CEO), Celtor Biosystems Inc (EVP), Combio AS (CEO), Natimmune AS (CEO), Aros Pharma ApS (CEO) and most recently Epitherapeutics ApS sold to Gilead Sciences in May 2015 for $65M
  • His experience includes a significant number of transactions within business development, trade sales, mergers & acquisitions as well as management of research & development

 

If you can't find it here or have feedback to our website, please do not hesitate to contact dd@danskbiotek.dk or 28895854

Copyright 2010 Danskbiotek. All rights reserved.